Additionally, bulk CD8+ cell selection and lymphodepletion/CAR-T dose interaction (which means that the lymphodepletion regimen more greatly associates with CRS as CAR-T dose increases) are correlated with elevated risk of CRS34. The gene discussed is CD8A; the disease is congenital rubella syndrome.